Chrome Extension
WeChat Mini Program
Use on ChatGLM

A Phase II Clinical Trial of Apatinib in Pretreated Advanced Non-squamous Non–small-cell Lung Cancer

Clinical Lung Cancer(2018)

Cited 57|Views26
No score
Abstract
Apatinib shows promising efficacy and manageable toxicity in patients with advanced non-squamous non-small-cell lung cancer. Apatinib therapy beyond progression could provide further benefits in specific subpopulations.
More
Translated text
Key words
Anti-angiogenesis,NSCLC,Targeted therapy,VEGFR-2
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined